At the Advances in Genome Biology and Technology meeting, various companies shared product updates about their sequencing instruments. The key updates include the departure of Singular Genomics from the group due to a shift in focus and acquisition, Element Biosciences’ innovation roadmap for its AVITI24™ sequencing system, the collaboration between Illumina and Nvidia for drug discovery, and MGI Tech’s upgraded DNBSEQ sequencers. Other companies discussed were Oxford Nanopore Technologies and Thermo Fisher Scientific, who are also working on multiomics and precision medicine respectively.
HIPAA Security Rule Amendment: Key Public Comments and Next Steps
The U.S. Department of Health and Human Services (HHS) is updating the Health Insurance Portability and Accountability Act (HIPAA) security standards amid changing technology and
